Price Targets

David Bellinger from Mizuho Securities issued a price target of $3,600.00 for AZO on 2026-03-05 11:41:00.The adjusted price target was set to $3,600.00.At the time of the announcement,

March 5, 2026   AZO -0.76%

Bill Sutherland from Cross Research issued a price target of $14.00 for CCRN on 2026-03-05 11:27:00.The adjusted price target was set to $14.00.At the time of the announcement,

March 5, 2026   CCRN -1.50%

from Piper Sandler issued a price target of $282.00 for ACN on 2026-03-05 06:05:00.The adjusted price target was set to $282.00.At the time of the announcement, ACN...

March 5, 2026   ACN 2.17%

Selman Akyol from Stifel Nicolaus issued a price target of $59.00 for MPLX on 2026-03-04 22:06:00.The adjusted price target was set to $59.00.At the time of the announcement,

March 4, 2026   MPLX -0.04%

Matthew Taylor from Jefferies issued a price target of $465.00 for SYK on 2026-03-04 22:00:00.The adjusted price target was set to $465.00.At the time of the announcement, SYK...

March 4, 2026   SYK 0.65%

Shlomo Rosenbaum from Stifel Nicolaus issued a price target of $50.40 for NATL on 2026-03-04 21:57:00.The adjusted price target was set to $50.40.At the time of the announcement,

March 4, 2026   NATL -0.02%

Selman Akyol from Stifel Nicolaus issued a price target of $58.00 for NWN on 2026-03-04 21:47:00.The adjusted price target was set to $58.00.At the time of the announcement,

March 4, 2026   NWN 1.79%

Annabel Samimy from Stifel Nicolaus issued a price target of $50.00 for OCS on 2026-03-04 21:46:00.The adjusted price target was set to $50.00.At the time of the announcement,

March 4, 2026   OCS -1.48%

from Wolfe Research issued a price target of $35.00 for EYE on 2026-03-04 21:40:00.The adjusted price target was set to $35.00.At the time of the announcement, EYE...

March 4, 2026   EYE -0.96%

Barry Jones from Truist Financial issued a price target of $13.00 for GENI on 2026-03-04 21:28:00.The adjusted price target was set to $13.00.At the time of the announcement,

March 4, 2026   GENI 0.44%